FogPharma lands $66 mln Series B
Cambridge, Massachusetts-based FogPharma, a developer of new treatments for cancer and other life-threatening diseases, has secured $66 million in Series B financing. The lead investor was 6 Dimensions Capital. Other investors that participated in the round included GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group, Leerink Partners Deerfield Management, Boyu Capital and WuXi AppTec Corporate Ventures.
21 May 2018•1 min read
